AmeriPath, Inc. to Present At Wachovia Securities' Twelfth Annual Nantucket Conference.Business Editors/Health & Medical Writers AmeriPath, Inc. (Nasdaq:PATH), one of the nation's leading providers of anatomic pathology services, today announced it will participate in the Wachovia Securities' Twelfth Annual Nantucket Conference to be held at the Harbor House Village in Nantucket, Massachusetts. The Company's Executive Vice President of Operations, Jim Billington, will make the AmeriPath presentation on Thursday, June 27th, 2002, at 2:00 p.m., Eastern Time. The public is invited to listen to a webcast of the live presentation via the Internet at the website URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. http://www.twst.com/econf/mm/fu8/path.html. The webcast and replay will also be available on the AmeriPath website, http://www.ameripath.com/. AmeriPath is a leading national provider of cancer diagnostics, genomics, and related information services. The Company's extensive diagnostics infrastructure includes the Center for Advanced Diagnostics (CAD), a division of AmeriPath. CAD provides specialized diagnostic testing and information services including Fluorescence In-Situ Hybridization hybridization /hy·brid·iza·tion/ (hi?brid-i-za´shun) 1. crossbreeding; the act or process of producing hybrids. 2. molecular hybridization 3. (FISH), Flow Cytometry, DNA Analysis, Polymerase Chain Reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is (PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) ), Molecular Genetics, Cytogenetics and HPV HPV human papillomavirus. HPV abbr. human papilloma virus Human papilloma virus (HPV) Typing. Additionally, AmeriPath provides clinical trial and research development support to firms involved in developing new cancer and genomic diagnostics and therapeutics. Editor's Note: This release is also available at http://www.ameripath.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion